Table 3: Patient characteristics by size of exposure.

 

Total

(n = 41)

< 1 cm exposure

(n = 18)

> 1 cm exposure

(n = 23)

p

Median months to removal (IQR)

42 (22-78)

39 (24-91)

45 (20-70)

0.96

Median months follow-up (IQR)

12 (2-25)

12 (2-19)

13 (1-44)

0.60

Median age at surgery (IQR)

54 (47-58)

56 (47-62)

53 (45-57)

0.21

Race

Black

2 (5%)

0 (0%)

2 (9%)

0.75

Hispanic

2 (5%)

1 (6%)

1 (4%)

 

Other

0 (0%)

0 (0%)

0 (0%)

 

White

37 (90%)

17 (94%)

20 (87%)

 

Median BMI (IQR)

27 (24-32)

27.6 (25-32)

27 (23-32)

0.59

Obese

14 (34%)

7 (39%)

7 (30%)

0.74

Diabetes status

Non-diabetic

35 (85%)

16 (89%)

19 (83%)

0.65

Type 2 diabetes

2 (5%)

0 (0%)

2 (9%)

 

Insulin-dependent

4 (10%)

2 (11%)

2 (9%)

 

Median gravida (IQR)

3 (2-3.5)

2 (2-3)

3 (2-4)

0.29

Median parity (IQR)

2 (2-3)

2 (2-3)

2 (2-3)

0.60

Hormone replacement therapy (HRT)

8 (24%)

3 (20%)

5 (26%)

> 0.99

Menopausal status and HRT

Pre-menopausal

21 (55%)

8 (47%)

13 (62%)

0.48

Post-menopausal, no HRT

12 (32%)

7 (41%)

5 (24%)

 

Post-menopausal, on HRT

5 (13%)

2 (12%)

3 (14%)

 

Hysterectomy

29 (81%)

12 (80%)

17 (81%)

> 0.99

Smoking status

Ever smoker

20 (49%)

9 (50%)

11 (48%)

> 0.99

Never smoker

21 (51%)

9 (50%)

12 (52%)

 

Type of tape

Retropubic

23 (56%)

8 (44%)

15 (65%)

0.65

Obturator

11 (27%)

6 (33%)

5 (22%)

 

Mini sling

2 (5%)

1 (6%)

1 (4%)

 

Multiple slings

5 (12%)

3 (17%)

2 (9%)

 

Unknown

0 (0%)

0 (0%)

0 (0%)

 

Symptoms present

Voiding dysfunction

18 (44%)

8 (44%)

10 (43%)

> 0.99

Dyspareunia

29 (71%)

12 (67%)

17 (74%)

0.73

Pain

24 (59%)

7 (39%)

17 (74%)

0.031

Stress urinary incontinence

19 (46%)

9 (50%)

10 (43%)

0.76

Urgency urinary incontinence

20 (49%)

12 (67%)

8 (35%)

0.061

Mixed urinary incontinence

14 (34%)

6 (33%)

8 (35%)

> 0.99

Urinary tract infections

17 (41%)

7 (39%)

10 (43%)

> 0.99